10-Q 1 thrm-10q_20190331.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission File Number: 0-21810

GENTHERM INCORPORATED

(Exact name of registrant as specified in its charter)

| Michigan |  | 95-4318554 |
| (State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.) |
| 21680 Haggerty Road, Northville, MI |  | 48167 |
| (Address of principal executive offices) |  | (Zip Code) |

Registrant’s telephone number, including area code: (248) 504-0500

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☒ |  | Accelerated filer | ☐
Non-accelerated filer | ☐ |  | Smaller reporting company | ☐
Emerging growth company | ☐ |  |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

At April 30, 2019, there were 33,675,021 issued and outstanding shares of Common Stock of the registrant.

GENTHERM INCORPORATED

TABLE OF CONTENTS

Cover
Table of Contents |  |
Part I. Financial Information |  | 3
| Item 1. |  | Financial Statements (Unaudited) |  | 3
|  |  | Consolidated Condensed Balance Sheets |  | 3
|  |  | Consolidated Condensed Statements of Income |  | 4
|  |  | Consolidated Condensed Statements of Comprehensive Income |  | 5
|  |  | Consolidated Condensed Statements of Cash Flows |  | 6
|  |  | Consolidated Condensed Statements of Changes in Shareholders’ Equity |  | 7
|  |  | Notes to Unaudited Consolidated Condensed Financial Statements |  | 8
| Item 2. |  | Management’s Discussion and Analysis of Financial Condition and Results of Operations |  | 25
| Item 3. |  | Quantitative and Qualitative Disclosures About Market Risk |  | 31
| Item 4. |  | Controls and Procedures |  | 32
Part II. Other Information |  | 33
| Item 1. |  | Legal Proceedings |  | 33
| Item 1A. |  | Risk Factors |  | 33
| Item 2. |  | Unregistered Sales of Equity Securities and Use of Proceeds |  | 33
| Item 6. |  | Exhibits |  | 34
Signatures |  | 35

2

PART I. FINANCIAL INFORMATION

ITEM 1. | FINANCIAL STATEMENTS

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

| March 31, 2019 |  |  | December 31, 2018 |
ASSETS |  |  |  |  |  |  |
Current Assets: |  |  |  |  |  |  |
Cash and cash equivalents | $ | 38,769 |  |  | $ | 39,620 |
Restricted cash |  | 2,500 |  |  |  | — |
Accounts receivable, less allowance of $1,068 and $851, respectively |  | 175,044 |  |  |  | 166,858 |
Inventory: |  |  |  |  |  |  |
Raw materials |  | 66,316 |  |  |  | 61,679 |
Work in process |  | 4,830 |  |  |  | 5,939 |
Finished goods |  | 40,979 |  |  |  | 44,917 |
Inventory, net |  | 112,125 |  |  |  | 112,535 |
Derivative financial instruments |  | 857 |  |  |  | 92 |
Prepaid expenses and other assets |  | 55,577 |  |  |  | 54,271 |
Assets held for sale |  | 17,009 |  |  |  | 69,699 |
Total current assets |  | 401,881 |  |  |  | 443,075 |
Property and equipment, net |  | 168,371 |  |  |  | 171,380 |
Goodwill |  | 54,721 |  |  |  | 55,311 |
Other intangible assets, net |  | 53,188 |  |  |  | 56,385 |
Operating lease right-of-use assets |  | 14,058 |  |  |  | — |
Deferred financing costs |  | 575 |  |  |  | 647 |
Deferred income tax assets |  | 61,032 |  |  |  | 64,024 |
Other non-current assets |  | 9,220 |  |  |  | 12,225 |
Total assets | $ | 763,046 |  |  | $ | 803,047 |
LIABILITIES AND SHAREHOLDERS’ EQUITY |  |  |  |  |  |  |
Current Liabilities: |  |  |  |  |  |  |
Accounts payable | $ | 91,286 |  |  | $ | 93,113 |
Accrued liabilities |  | 60,907 |  |  |  | 65,808 |
Current lease liabilities |  | 4,203 |  |  |  | — |
Current maturities of long-term debt |  | 2,949 |  |  |  | 3,413 |
Liabilities held for sale |  | 7,009 |  |  |  | 13,062 |
Total current liabilities |  | 166,354 |  |  |  | 175,396 |
Pension benefit obligation |  | 6,755 |  |  |  | 7,211 |
Non-current lease liabilities |  | 9,307 |  |  |  | — |
Long-term debt, less current maturities |  | 97,604 |  |  |  | 136,477 |
Deferred income tax liabilities |  | 1,649 |  |  |  | 1,177 |
Other non-current liabilities |  | 2,890 |  |  |  | 3,087 |
Total liabilities | $ | 284,559 |  |  | $ | 323,348 |
Shareholders’ equity: |  |  |  |  |  |  |
Common Stock: |  |  |  |  |  |  |
No par value; 55,000,000 shares authorized, 33,653,179 and 33,856,629 issued and outstanding at March 31, 2019 and December 31, 2018, respectively |  | 134,486 |  |  |  | 140,300 |
Paid-in capital |  | 14,513 |  |  |  | 14,934 |
Accumulated other comprehensive loss |  | (43,152 | ) |  |  | (39,500 | )
Accumulated earnings |  | 372,640 |  |  |  | 363,965 |
Total shareholders’ equity |  | 478,487 |  |  |  | 479,699 |
Total liabilities and shareholders’ equity | $ | 763,046 |  |  | $ | 803,047 |

See accompanying notes to the consolidated condensed financial statements.

3

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF INCOME

(In thousands, except per share data)

(Unaudited)

| Three Months Ended March 31, |
| 2019 |  |  | 2018 |
Product revenues | $ | 257,921 |  |  | $ | 264,586 |
Cost of sales |  | 182,614 |  |  |  | 183,344 |
Gross margin |  | 75,307 |  |  |  | 81,242 |
Operating expenses: |  |  |  |  |  |  |
Net research and development expenses |  | 18,897 |  |  |  | 23,304 |
Selling, general and administrative expenses |  | 32,613 |  |  |  | 36,424 |
Acquisition transaction expenses |  | 38 |  |  |  | — |
Restructuring expenses |  | 1,914 |  |  |  | 865 |
Total operating expenses |  | 53,462 |  |  |  | 60,593 |
Operating income |  | 21,845 |  |  |  | 20,649 |
Interest expense |  | (1,368 | ) |  |  | (1,180 | )
Foreign currency gain (loss) |  | 203 |  |  |  | (4,578 | )
Gain on sale of business |  | 4,970 |  |  |  | — |
Impairment loss |  | (10,484 | ) |  |  | — |
Other income |  | 143 |  |  |  | 1,111 |
Earnings before income tax |  | 15,309 |  |  |  | 16,002 |
Income tax expense |  | 6,895 |  |  |  | 3,036 |
Net income | $ | 8,414 |  |  | $ | 12,966 |
Basic earnings per share | $ | 0.25 |  |  | $ | 0.35 |
Diluted earnings per share | $ | 0.25 |  |  | $ | 0.35 |
Weighted average number of shares – basic |  | 33,573 |  |  |  | 36,766 |
Weighted average number of shares – diluted |  | 33,733 |  |  |  | 36,873 |

See accompanying notes to the consolidated condensed financial statements.

4

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

| Three Months Ended March 31, |
| 2019 |  |  | 2018 |
Net income | $ | 8,414 |  |  | $ | 12,966 |
Other comprehensive (loss) income, gross of tax: |  |  |  |  |  |  |
Foreign currency translation adjustments (loss) gain |  | (4,074 | ) |  |  | 11,741 |
Unrealized gain on foreign currency derivative securities |  | 766 |  |  |  | 2,112 |
Unrealized loss on commodity derivative securities |  | — |  |  |  | (218 | )
Other comprehensive (loss) income, gross of tax | $ | (3,308 | ) |  | $ | 13,635 |
Other comprehensive (loss) income, related tax effect: |  |  |  |  |  |  |
Cumulative effect of accounting change due to ASU 2018-02 |  | — |  |  |  | (40 | )
Foreign currency translation adjustments (loss) gain |  | (177 | ) |  |  | (76 | )
Unrealized gain on foreign currency derivative securities |  | (167 | ) |  |  | (567 | )
Unrealized loss on commodity derivative securities |  | — |  |  |  | (59 | )
Other comprehensive (loss) income, related tax effect | $ | (344 | ) |  | $ | (742 | )
Other comprehensive (loss) income, net of tax | $ | (3,652 | ) |  | $ | 12,893 |
Comprehensive income | $ | 4,762 |  |  | $ | 25,859 |

See accompanying notes to the consolidated condensed financial statements.

5

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

| Three Months Ended March 31, |
| 2019 |  |  | 2018 |
Operating Activities: |  |  |  |  |  |  |
Net income | $ | 8,414 |  |  | $ | 12,966 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |  |  |  |
Depreciation and amortization |  | 11,052 |  |  |  | 12,892 |
Deferred income taxes |  | 1,749 |  |  |  | (707 | )
Stock compensation |  | 1,968 |  |  |  | 2,202 |
Defined benefit plan (income) expense |  | (617 | ) |  |  | 298 |
Provision of doubtful accounts |  | 229 |  |  |  | 41 |
Loss on sale of property and equipment |  | 178 |  |  |  | 85 |
Operating lease expense |  | 1,333 |  |  |  | — |
Impairment loss |  | 10,484 |  |  |  | — |
Gain on sale of business |  | (4,970 | ) |  |  | — |
Changes in assets and liabilities: |  |  |  |  |  |  |
Accounts receivable |  | (8,293 | ) |  |  | (9,691 | )
Inventory |  | (229 | ) |  |  | 1,903 |
Prepaid expenses and other assets |  | (5,553 | ) |  |  | (4,881 | )
Accounts payable |  | (2,079 | ) |  |  | 1,290 |
Accrued liabilities |  | (6,785 | ) |  |  | (10,808 | )
Net cash provided by operating activities |  | 6,881 |  |  |  | 5,590 |
Investing Activities: |  |  |  |  |  |  |
Proceeds from the sale of property and equipment |  | 28 |  |  |  | — |
Proceeds from sale of a business |  | 47,500 |  |  |  | — |
Final payment for acquisition of subsidiary, net of cash acquired |  | — |  |  |  | (15 | )
Purchases of property and equipment |  | (5,150 | ) |  |  | (8,378 | )
Net cash provided by (used in) investing activities |  | 42,378 |  |  |  | (8,393 | )
Financing Activities: |  |  |  |  |  |  |
Borrowing of debt |  | 10,428 |  |  |  | — |
Repayments of debt |  | (49,627 | ) |  |  | (35,492 | )
Cash paid for the cancellation of restricted stock |  | (376 | ) |  |  | (659 | )
Proceeds from the exercise of Common Stock options |  | 214 |  |  |  | 751 |
Repurchase of Common Stock |  | (8,040 | ) |  |  | — |
Net cash used in financing activities |  | (47,401 | ) |  |  | (35,400 | )
Foreign currency effect |  | (209 | ) |  |  | 5,513 |
Net increase (decrease) in cash, cash equivalents and restricted cash |  | 1,649 |  |  |  | (32,690 | )
Cash, cash equivalents and restricted cash at beginning of period |  | 39,620 |  |  |  | 103,172 |
Cash, cash equivalents and restricted cash at end of period | $ | 41,269 |  |  | $ | 70,482 |
Supplemental disclosure of cash flow information: |  |  |  |  |  |  |
Cash paid for taxes | $ | 3,466 |  |  | $ | 6,870 |
Cash paid for interest | $ | 1,252 |  |  | $ | 981 |
Supplemental disclosure of non-cash transactions: |  |  |  |  |  |  |
Common Stock issued to Board of Directors and employees | $ | 1,581 |  |  | $ | 1,362 |

See accompanying notes to the consolidated condensed financial statements.

6

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(In thousands)

(Unaudited)

|  |  |  |  |  |  |  |  |  |  |  |  | Accumulated |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  |  | Other |  |  |  |  |  |  |  |
| Common Stock |  |  | Paid-in |  |  | Comprehensive |  |  | Accumulated |  |  |  |  |
| Shares |  |  | Amount |  |  | Capital |  |  | Income (Loss) |  |  | Earnings |  |  | Total |
Balance at December 31, 2018 |  | 33,857 |  |  | $ | 140,300 |  |  | $ | 14,934 |  |  | $ | (39,500 | ) |  | $ | 363,965 |  |  | $ | 479,699 |
Cumulative effect of accounting change due to adoption of ASU 2016-02 |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 261 |  |  |  | 261 |
Stock repurchase |  | (200 | ) |  |  | (8,040 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (8,040 | )
Exercise of Common Stock options for cash |  | 13 |  |  |  | 1,021 |  |  |  | (807 | ) |  |  | — |  |  |  | — |  |  |  | 214 |
Cancellation of restricted stock |  | (17 | ) |  |  | (376 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (376 | )
Stock option compensation |  | — |  |  |  | — |  |  |  | 386 |  |  |  | — |  |  |  | — |  |  |  | 386 |
Common Stock issued to Board of Directors and employees |  | — |  |  |  | 1,581 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,581 |
Currency translation, net |  | — |  |  |  | — |  |  |  | — |  |  |  | (4,251 | ) |  |  | — |  |  |  | (4,251 | )
Foreign currency hedge, net |  | — |  |  |  | — |  |  |  | — |  |  |  | 599 |  |  |  | — |  |  |  | 599 |
Net income |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 8,414 |  |  |  | 8,414 |
Balance at March 31, 2019 |  | 33,653 |  |  | $ | 134,486 |  |  | $ | 14,513 |  |  | $ | (43,152 | ) |  | $ | 372,640 |  |  | $ | 478,487 |

|  |  |  |  |  |  |  |  |  |  |  |  | Accumulated |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  |  | Other |  |  |  |  |  |  |  |
| Common Stock |  |  | Paid-in |  |  | Comprehensive |  |  | Accumulated |  |  |  |  |
| Shares |  |  | Amount |  |  | Capital |  |  | Income (Loss) |  |  | Earnings |  |  | Total |
Balance at December 31, 2017 |  | 36,761 |  |  | $ | 265,048 |  |  | $ | 15,625 |  |  | $ | (20,444 | ) |  | $ | 293,645 |  |  | $ | 553,874 |
Cumulative effect of accounting change due to adoption of ASU 2014-09 |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (3,264 | ) |  |  | (3,264 | )
Cumulative effect of accounting change due to adoption of ASU 2016-16 |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 31,645 |  |  |  | 31,645 |
Cumulative effect of accounting change due to adoption of ASU 2018-02 |  | — |  |  |  | — |  |  |  | — |  |  |  | (40 | ) |  |  | 40 |  |  |  | — |
Exercise of Common Stock options for cash |  | 57 |  |  |  | 1,061 |  |  |  | (310 | ) |  |  | — |  |  |  | — |  |  |  | 751 |
Cancellation of restricted stock |  | (24 | ) |  |  | (659 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (659 | )
Restricted stock and stock option compensation |  | — |  |  |  | 1,362 |  |  |  | 840 |  |  |  | — |  |  |  | — |  |  |  | 2,202 |
Currency translation, net |  | — |  |  |  | — |  |  |  | — |  |  |  | 11,665 |  |  |  | — |  |  |  | 11,665 |
Foreign currency hedge, net |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,545 |  |  |  | — |  |  |  | 1,545 |
Commodity hedge, net |  | — |  |  |  | — |  |  |  | — |  |  |  | (277 | ) |  |  | — |  |  |  | (277 | )
Net income |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 12,966 |  |  |  | 12,966 |
Balance at March 31, 2018 |  | 36,794 |  |  | $ | 266,812 |  |  | $ | 16,155 |  |  | $ | (7,551 | ) |  | $ | 335,032 |  |  | $ | 610,448 |

See accompanying notes to the consolidated condensed financial statements.

7

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 1 – The Company and Subsequent Events

Gentherm Incorporated is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies. Unless the context otherwise requires, the terms “Gentherm”, “Company”, “we”, “us” and “our” used herein refer to Gentherm Incorporated and its consolidated subsidiaries. Our products provide solutions for automotive passenger climate comfort and convenience, battery thermal management and cell connecting systems, as well as patient temperature management within the health care industry. Our automotive products can be found on the vehicles of nearly all major automotive manufacturers operating in North America, Europe and Asia. We operate in locations aligned with our major customers’ product strategies to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies and new applications from existing technologies to create product and market opportunities for a wide array of thermal management solutions.

Sale of Cincinnati Sub-Zero Industrial Chamber Business (CSZ-IC)

On February 1, 2019, as part of the Company’s Fit-for-Growth initiative to eliminate investments in non-core businesses, we completed the sale of the Cincinnati Sub-Zero industrial chamber business (“CSZ-IC”) and former Cincinnati Sub-Zero headquarters facility to Weiss Technik North America, Inc. for total cash proceeds of $47,500, including $2,500 of the cash proceeds were placed into an escrow account for a period of up to one year as partial security for the Company’s obligations under the sale agreement. In connection with the sale, Gentherm entered into an operating lease agreement for a portion of the office and manufacturing building space purchased by Weiss Technik North America, Inc. The Company recognized a $4,970 pre-tax gain on the sale of CSZ-IC during the three-month period ended March 31, 2019.

Fit-for-Growth

Gentherm recognized $395 and $0 of one-time employee termination costs in restructuring expenses pertaining to Fit-for-Growth during the three-month periods ended March 31, 2019 and 2018, respectively. Gentherm recognized $4 and $0 of contract termination costs in restructuring expenses pertaining to Fit-for-Growth during the respective three-month periods ended March 31, 2019 and 2018, respectively.

GPT and CSZ-IC

During 2018, Gentherm launched a program to actively market GPT and CSZ-IC and initiated all other actions required to complete the divestiture plan. Gentherm incurred $839 of consultant costs in restructuring expenses to execute the plan. Lastly, Gentherm recognized $251 of one-time employee termination costs in restructuring expenses related to the divestiture process during the three-month period ended March 31, 2019. See Note 12 to our consolidated condensed financial statements for additional information regarding the assets and liabilities classified as held for sale.

Restructuring Liability

Restructuring liabilities totaling $1,358 and $2,547 as of March 31, 2019 and December 31, 2018, respectively, are classified as accrued liabilities on the consolidated condensed balance sheets. A reconciliation of the beginning and ending restructuring liability is as follows:

|  | One-Time Employee Termination Benefit Costs |  |  | Contract Termination Costs |  |  | Consulting Costs |  |  | Asset Disposal Costs |  |  | Total |
Three Months Ended March 31, 2019 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, beginning of period |  | $ | 2,079 |  |  | $ | 389 |  |  | $ | 79 |  |  | $ | — |  |  | $ | 2,547 |
Additions, charged to restructuring expenses |  |  | 646 |  |  |  | 4 |  |  |  | 839 |  |  |  | 425 |  |  |  | 1,914 |
Payments |  |  | (1,675 | ) |  |  | (88 | ) |  |  | (915 | ) |  |  | (425 | ) |  |  | (3,103 | )
Balance, end of period |  | $ | 1,050 |  |  | $ | 305 |  |  | $ | 3 |  |  | $ | — |  |  | $ | 1,358 |

8

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 1 – The Company and Subsequent Events – Continued

The cumulative amount of restructuring expenses incurred and recognized in the automotive and industrial reporting segments during the three-month period ended March 31, 2019 was $368 and $1,546, respectively.

Subsequent Events

On April 1, 2019, we acquired all of the equity interests of Stihler Electronic GmbH (“Stihler”) in an all-cash transaction for approximately $15,000, net of cash acquired, and an additional cash payment of up to $1,700 contingent upon achievement of future milestones. Based in Stuttgart, Germany, Stihler manufactures high quality patient and blood temperature systems and other medical equipment for the health care industry.

Note 2 – Summary of Significant Accounting Policies and Basis of Presentation

Accounting Principles

Our unaudited consolidated condensed financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in the audited annual consolidated financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been condensed or omitted pursuant to those rules and regulations. In the opinion of management, all adjustments, consisting of normal recurring items, considered necessary for a fair presentation of our results of operations, financial position and cash flows have been included. The balance sheet as of December 31, 2018 was derived from audited annual consolidated financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America. Certain reclassifications of prior year’s amounts have been made to conform with the current year’s presentation. Notably, for the three-month period ended March 31, 2018, $2,697 in customer relationship amortization was reclassified from product revenues to selling, general and administrative expenses. Operating results for the three-month period ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019. These consolidated condensed financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2018.

Consolidation

The consolidated condensed financial statements at March 31, 2019 and December 31, 2018 and for the three-month periods ended March 31, 2019 and 2018, reflect the consolidated financial position, the consolidated operating results and the consolidated cash flows of the Company. Investments in affiliates in which Gentherm would not have control, but would have the ability to exercise significant influence over operating and financial policies, would be accounted for under the equity method. All other equity investments are measured at cost, less impairment, with changes in fair value recognized in net income.

Use of Estimates

The presentation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Actual results could differ from those estimates and assumptions.

9

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 2 – Summary of Significant Accounting Policies and B asis of Presentation – Continued

Cash, cash equivalents and restricted cash

The Company has cash that is legally restricted as to use or withdrawal. A reconciliation of cash and cash equivalents on the consolidated condensed balance sheets to cash, cash equivalents and restricted cash presented on the consolidated condensed statements of cash flows is as follows:

Year |  | March 31, 2019 |  |  | December 31, 2018 |  |  | March 31, 2018 |  |  | December 31, 2017 |
Cash and cash equivalents presented in the consolidated condensed balance sheets |  | $ | 38,769 |  |  | $ | 39,620 |  |  | $ | 70,482 |  |  | $ | 103,172 |
Restricted cash |  |  | 2,500 |  |  |  | — |  |  |  | — |  |  |  | — |
Cash, cash equivalents and restricted cash presented in the consolidated condensed statements of cash flows |  | $ | 41,269 |  |  | $ | 39,620 |  |  | $ | 70,482 |  |  | $ | 103,172 |

Leases

The Company determines whether a contractual arrangement is or contains a lease at inception. Leases that are operating in nature are recognized in operating lease right-of-use assets, accrued liabilities and lease liabilities on our consolidated condensed balance sheet. While Gentherm is not currently party to any leases that qualify as financing leases, right-of-use assets and liabilities recognized from financing leases would be presented separately from the right-of-use assets and liabilities recognized from operating leases on our consolidated condensed balance sheet.

Lease liabilities are measured initially at the present value of the sum of the future minimum rental payments at the commencement date of the lease. Lease payments that will vary in the future due changes in facts and circumstances are excluded from the calculation of rental payments, unless those variable payments are based on an index or rate. Rental payments are discounted using an incremental borrowing rate based on the Company’s credit rating, determined on a fully collateralized loan basis from information available at commencement date, and the duration of the lease term (the “reference rate”). Judgement is used to assess the importance of risk factor inputs during the computation of the Company’s credit rating. For significant leases at foreign subsidiaries denominated in U.S. Dollars, a risk premium associated with the borrower subsidiary’s country is added to the reference rate. For significant leases at foreign subsidiaries denominated in a foreign currency, the U.S. Dollar risk free rate with a duration similar to that of the lease term is subtracted from the reference rate and a corresponding foreign currency risk free rate with a duration similar to that of the lease term is added to the reference rate. Judgement is used to determine whether foreign subsidiary leases are significant.

Operating lease right-of-use assets are measured at the amount of the lease liability, adjusted for prepaid or accrued lease payments, lease incentive received, and initial direct costs incurred, as applicable. Periods covered by an option to extend the lease are initially included in the measurement of an operating lease right-of-use asset and lease liability only when it is reasonably certain we will exercise the option. Gentherm’s lease agreements do not contain residual value guarantees or impose restrictions or covenants on the Company.

For all classes of underlying assets, the Company accounts for leases that contain separate lease and nonlease components as containing a single lease component. The Company does not recognize lease right-of-use assets and lease liabilities from leases with an original lease term of 12 months or less and, instead, recognizes rent payments on a straight-line basis over the lease term in the Company’s consolidated condensed statement of income. See Note 10 to our consolidated condensed financial statements for description of the changes made to our accounting policy for leases that resulted from the adoption of a new lease standard.

Impairments of Goodwill and Other Intangible Assets

Whenever events or changes in circumstances indicate that it is more likely than not that a reporting unit’s fair value is less than is carrying amount, the Company then compares the fair value of the reporting unit to the related net book value. If the net book value of a reporting unit exceeds its fair value, an impairment loss is measured and recognized. The fair value of a reporting unit is estimated by analyzing internal inputs (level 3) to calculate forward values and discounting those values to the present value.

10

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 2 – Summary of Significant Accounting Policies and Basis of Presentation – Continued

There were no events or changes in circumstances which would indicate goodwill was impaired or potentially impaired during the three-months ended March 31, 2019.

A rolled forward reconciliation of goodwill from December 31, 2018 to March 31, 2019 is as follows:

Three Months Ended March 31, 2019 |  |  |
Balance, beginning of period | $ | 55,311 |
Currency impact |  | (590 | )
Balance, end of period | $ | 54,721 |

Assets and Liabilities Held for Sale

The Company classifies assets and liabilities (disposal groups) to be sold as held for sale in the period in which all of the following criteria are met: management, having the authority to approve the action, commits to a plan to sell the disposal group; the disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such disposal groups; an active program to locate a buyer and other actions required to complete the plan to sell the disposal group have been initiated; the sale of the disposal group is probable, and transfer of the disposal group is expected to qualify as a completed sale within one year, except if events or circumstances beyond the Company’s control extend the period of time required to sell the disposal group beyond one year; the disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.

The Company initially measures a disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Gains are not recognized on the sale of a disposal group until the date of sale. The Company assesses the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and reports any subsequent losses as an adjustment to the carrying value of the disposal group.

The Company reports assets and liabilities of the disposal group in the line items assets held for sale and liabilities held for sale in the consolidated condensed balance sheet in the period the disposal group meets the criteria to be classified as held for sale. See Note 12 to our consolidated condensed financial statement for information about the assets and liabilities classified as held for sale.

11

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 3 – Earnings Per Share

Basic earnings per share are computed by dividing net income by the weighted average number of shares of stock outstanding during the period. The Company’s diluted earnings per share give effect to all potential Common Stock outstanding during a period that do not have an anti-dilutive impact to the calculation. In computing the diluted earnings per share, the treasury stock method is used in determining the number of shares assumed to be issued from the exercise of Common Stock equivalents.

The following summarizes the Common Stock included in the basic and diluted shares, as disclosed on the face of the consolidated condensed statements of income:

| Three Months Ended March 31, |
| 2019 |  |  | 2018 |
Weighted average number of shares for calculation of basic EPS |  | 33,573,411 |  |  |  | 36,766,411 |
Stock options, restricted stock awards and restricted stock units under equity incentive plans |  | 159,924 |  |  |  | 106,996 |
Weighted average number of shares for calculation of diluted EPS |  | 33,733,335 |  |  |  | 36,873,407 |

The following table represents Common Stock issuable upon the exercise of certain stock options that have been excluded from the diluted earnings calculation because the effect of their inclusion would be anti-dilutive.

| Three Months Ended March 31, |
| 2019 |  |  | 2018 |
Stock options under equity incentive plans |  | 396,500 |  |  |  | 1,914,150 |

Note 4 – Segment Reporting

Segment information is used by management for making strategic operating decisions for the Company. Management evaluates the performance of the Company’s segments based primarily on operating income or loss.

The Company’s reportable segments are as follows:

| ● | Automotive – this segment represents the design, development, manufacturing and sales of automotive climate control seat (CCS) products, seat heaters, steering wheel heaters, automotive cables, battery thermal management (BTM), electronics and other automotive products.

| • | Industrial – the combined operating results of GPT, Gentherm Medical and Gentherm’s advanced research and development division. We perform advanced research and development on thermal management systems, including those that utilize new proprietary comfort software algorithms, to enhance the efficiency and functionality of our automotive heating and cooling products. Unlike research and development that relates to a specific product application for a customer, advanced research and development activities affect products and technologies that are not currently generating product revenues. The segment includes government sponsored research projects.

| ● | Reconciling Items – include corporate selling, general and administrative costs and acquisition transaction costs.

12

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 4 – Segment Reporting – Continued

The tables below present segment information about the reported product revenues, depreciation and amortization and operating income (loss) of the Company for three-month period ended March 31, 2019 and 2018. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level. As of March 31, 2019, goodwill assigned to our Automotive and Industrial segments were $36,943 and $17,778, respectively. As of March 31, 2018, goodwill assigned to our Automotive and Industrial segments were $39,666 and $30,773, respectively.

Three Months Ended March 31, | Automotive |  |  | Industrial(1) |  |  | Reconciling Items |  |  | Consolidated Total |
2019: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Product revenues | $ | 242,357 |  |  | $ | 15,564 |  |  | $ | — |  |  | $ | 257,921 |
Depreciation and amortization |  | 10,296 |  |  |  | 290 |  |  |  | 466 |  |  |  | 11,052 |
Operating income (loss) |  | 39,896 |  |  |  | (4,514 | ) |  |  | (13,537 | ) |  |  | 21,845 |
2018: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Product revenues(1) | $ | 242,716 |  |  | $ | 21,870 |  |  | $ | — |  |  | $ | 264,586 |
Depreciation and amortization |  | 10,809 |  |  |  | 1,351 |  |  |  | 732 |  |  |  | 12,892 |
Operating income (loss) |  | 41,282 |  |  |  | (6,798 | ) |  |  | (13,835 | ) |  |  | 20,649 |

| (1) | Industrial segment includes $3,418 and $10,213 in product revenues, $0 and $625 in depreciation and amortization, and $198 and $600 in operating income from CSZ-IC for the three-month periods ended March 31, 2019 and 2018, respectively. On February 1, 2019, we completed the sale of CSZ-IC.

Automotive and Industrial segment product revenues by product category for the three months ended March 31, 2019 and 2018 are as follows:

|  | Three Months Ended March 31, |
|  | 2019 |  |  | 2018 |  |  | % Change
Climate Control Seats (CCS) |  | $ | 94,354 |  |  | $ | 88,218 |  |  | 7.0 |  | %
Seat Heaters |  |  | 73,920 |  |  |  | 84,220 |  |  | (12.2 | ) | %
Steering Wheel Heaters |  |  | 16,970 |  |  |  | 17,557 |  |  | (3.3 | ) | %
Automotive Cables |  |  | 23,749 |  |  |  | 26,865 |  |  | (11.6 | ) | %
Battery Thermal Management (BTM)(a) |  |  | 10,745 |  |  |  | 4,161 |  |  | 158.2 |  | %
Electronics |  |  | 12,852 |  |  |  | 15,188 |  |  | (15.4 | ) | %
Other Automotive |  |  | 9,767 |  |  |  | 6,212 |  |  | 57.2 |  | %
Subtotal Automotive |  | $ | 242,357 |  |  | $ | 242,421 |  |  | — |  | %
Remote Power Generation (GPT) |  |  | 3,959 |  |  |  | 4,662 |  |  | (15.1 | ) | %
Industrial Chambers |  |  | 3,418 |  |  |  | 10,213 |  |  | (66.5 | ) | %
Gentherm Medical |  |  | 8,187 |  |  |  | 7,290 |  |  | 12.3 |  | %
Subtotal Industrial |  | $ | 15,564 |  |  | $ | 22,165 |  |  | (29.8 | ) | %
Total Company |  | $ | 257,921 |  |  | $ | 264,586 |  |  | (2.5 | ) | %

| a) | Battery Thermal Management or BTM product revenues include Gentherm’s automotive grade, low cost, heat resistant fans and blowers used by customer for battery cooling through ventilation and production level shipments of the advanced TED based active cool system.

13

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 4 – Segment Reporting – Continued

Total product revenues information by geographic area is as follows (based on shipment destination):

| Three Months Ended March 31, |
| 2019 |  |  | 2018 |
United States | $ | 118,454 |  |  |  | 46 | % |  | $ | 120,350 |  |  |  | 46 | %
Germany |  | 23,210 |  |  |  | 9 | % |  |  | 22,362 |  |  |  | 8 | %
Japan |  | 18,591 |  |  |  | 7 | % |  |  | 13,573 |  |  |  | 5 | %
China |  | 15,597 |  |  |  | 6 | % |  |  | 24,204 |  |  |  | 9 | %
South Korea |  | 14,978 |  |  |  | 6 | % |  |  | 13,822 |  |  |  | 5 | %
Czech Republic |  | 12,142 |  |  |  | 5 | % |  |  | 11,715 |  |  |  | 5 | %
Canada |  | 10,291 |  |  |  | 4 | % |  |  | 13,113 |  |  |  | 5 | %
United Kingdom |  | 8,832 |  |  |  | 3 | % |  |  | 10,845 |  |  |  | 4 | %
Romania |  | 6,922 |  |  |  | 3 | % |  |  | 6,298 |  |  |  | 2 | %
Other |  | 28,904 |  |  |  | 11 | % |  |  | 28,304 |  |  |  | 11 | %
Total Non-U.S. |  | 139,467 |  |  |  | 54 | % |  |  | 144,236 |  |  |  | 54 | %
| $ | 257,921 |  |  |  | 100 | % |  | $ | 264,586 |  |  |  | 100 | %

Note 5 – Debt

Amended Credit Agreement

The Company has an outstanding credit agreement (the “Credit Agreement”) with a consortium of lenders and Bank of America, N.A., as administrative agent. The Credit Agreement provides the Company a revolving credit note (“U.S. Revolving Note”) with a maximum borrowing capacity of $350,000.

All subsidiary borrowers and guarantors participating in the Credit Agreement have entered into a related pledge and security agreement. The security agreement grants a security interest to the lenders in substantially all of the personal property of subsidiaries designated as borrowers to secure their respective obligations under the Credit Agreement, including the stock and membership interests of specified subsidiaries (limited to 66% of the stock in the case of certain non-U.S. subsidiaries). The Credit Agreement restricts the amount of dividend payments the Company can make to shareholders.

The Credit Agreement requires the Company to maintain a minimum Consolidated Interest Coverage Ratio and Consolidated Leverage Ratio. Definitions for these financial ratios are provided in the Credit Agreement.

Under the Credit Agreement, U.S. Dollar denominated loans bear interest at either a base rate (“Base Rate Loans”) or Eurocurrency rate (“Eurocurrency Rate Loans”), plus a margin (“Applicable Rate”). The rate for Base Rate Loans is equal to the highest of the Federal Funds Rate (2.43% at March 31, 2019) plus 0.50%, Bank of America’s prime rate (5.50% at March 31, 2019), or a one-month Eurocurrency rate (0.00% at March 31, 2019) plus 1.00%. The rate for Eurocurrency Rate Loans denominated in U.S. Dollars is equal to the London Interbank Offered Rate (2.49% at March 31, 2019). All loans denominated in a currency other than the U.S. Dollar must be Eurocurrency Rate Loans. Interest is payable at least quarterly.

The Applicable Rate varies based on the Consolidated Leverage Ratio reported by the Company. As long as the Company is not in default of the terms and conditions of the Credit Agreement, the lowest and highest possible Applicable Rate is 1.25% and 2.00%, respectively, for Eurocurrency Rate Loans and 0.25% and 1.00%, respectively, for Base Rate Loans.

The Company also has two fixed interest rate loans with the German Investment Corporation (“DEG”), a subsidiary of KfW Banking Group, a Germany government-owned development bank.

14

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 5 – Debt – Continued

DEG China Loan

The first DEG loan, a loan we used to fund capital investments in China (the “DEG China Loan”), is subject to semi-annual principal payments that began March, 2015 and will end September, 2019. Under the terms of the DEG China Loan, the Company must maintain a minimum Debt-to-Equity Ratio, Current Ratio and Debt Service Coverage Ratio, as defined by the DEG China Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Automotive Systems (China) Ltd.

DEG Vietnam Loan

The Company’s second fixed interest rate loan agreement with DEG was used to finance the construction and set up of the Vietnam production facility (“DEG Vietnam Loan”). The DEG Vietnam Loan is subject to semi-annual principal payments that began November, 2017 and will end May, 2023. Under the terms of the DEG Vietnam Loan, the Company must maintain a minimum Equity Ratio and Enhanced Equity Ratio, as defined by the DEG Vietnam Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Vietnam Co. Ltd.

Undrawn borrowing capacity under the U.S. Revolving Note was $261,071 as of March 31, 2019. The following table summarizes the Company’s debt at March 31, 2019 and at December 31, 2018.

| March 31, 2019 |  |  | December 31, 2018 |
| Interest Rate |  |  | Principal Balance |  |  | Principal Balance |
Credit Agreement: |  |  |  |  |  |  |  |  |  |  |
U.S. Revolving Note (U.S. Dollar Denominations) |  | 4.00 | % |  | $ | 81,000 |  |  | $ | 122,000 |
U.S. Revolving Note (Euro Denominations) |  | 1.50 | % |  |  | 7,854 |  |  |  | 5,727 |
DEG China Loan |  | 4.25 | % |  |  | 449 |  |  |  | 913 |
DEG Vietnam Loan |  | 5.21 | % |  |  | 11,250 |  |  |  | 11,250 |
Total debt |  |  |  |  |  | 100,553 |  |  |  | 139,890 |
Current portion |  |  |  |  |  | (2,949 | ) |  |  | (3,413 | )
Long-term debt, less current maturities |  |  |  |  | $ | 97,604 |  |  | $ | 136,477 |

The scheduled principal maturities of our debt as of March 31, 2019 are as follows:

Year |  | U.S. Revolving Note |  |  | DEG China Note |  |  | DEG Vietnam Note |  |  | Total |
Remainder of 2019 |  | $ | — |  |  | $ | 449 |  |  | $ | 2,500 |  |  | $ | 2,949 |
2020 |  |  | — |  |  |  | — |  |  |  | 2,500 |  |  |  | 2,500 |
2021 |  |  | 88,854 |  |  |  | — |  |  |  | 2,500 |  |  |  | 91,354 |
2022 |  |  | — |  |  |  | — |  |  |  | 2,500 |  |  |  | 2,500 |
2023 |  |  | — |  |  |  | — |  |  |  | 1,250 |  |  |  | 1,250 |
Total |  | $ | 88,854 |  |  | $ | 449 |  |  | $ | 11,250 |  |  | $ | 100,553 |

Principal outstanding under the U.S. Revolving Note will be due and payable in full on March 17, 2021. As of March 31, 2019, we were in compliance, in all material respects, with all terms as outlined in the Credit Agreement, DEG China Loan and DEG Vietnam Loan.

15

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 6 – Derivative Financial Instruments

We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $24,114 and $33,250 outstanding as of March 31, 2019 and December 31, 2018, respectively.

The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years. No commodity swap contracts were outstanding at March 31, 2019 or at December 31, 2018.

We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive loss in the consolidated balance sheet. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive loss is recorded in earnings in the consolidated statement of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated statements of income. See Note 8 for the amount of unrealized loss associated with foreign currency derivatives reported in accumulated other comprehensive income as of December 31, 2018 that was reclassified into earnings during 2019. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term.

Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of March 31, 2019 is as follows:

|  |  |  |  |  | Asset Derivatives |  |  | Liability Derivatives |  |  | Net Asset/ (Liabilities) |
|  | Hedge Designation |  | Fair Value Hierarchy |  | Balance Sheet Location |  |  | Fair Value |  |  | Balance Sheet Location |  | Fair Value |  |
Foreign currency derivatives |  | Cash flow hedge |  | Level 2 |  |  | Current assets |  |  | $ | 857 |  |  | Current liabilities |  | $ | — |  |  | $ | 857 |

16

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 6 – Derivative Financial Instruments – Continued

Information relating to the effect of derivative instruments on our consolidated condensed statements of income is as follows:

|  | Location |  |  | Three Months Ended March 31, 2019 |  |  | Three Months Ended March 31, 2018 |
Foreign currency derivatives |  | Cost of sales |  |  | $ | 240 |  |  | $ | (81 | )
|  | Selling, general and administrative |  |  |  | — |  |  |  | 53 |
|  | Other comprehensive income |  |  |  | 766 |  |  |  | 2,112 |
|  | Foreign currency (loss) gain |  |  |  | (37 | ) |  |  | 37 |
Total foreign currency derivatives |  |  |  |  | $ | 969 |  |  | $ | 2,121 |
Commodity derivatives |  | Cost of sales |  |  | $ | — |  |  | $ | 145 |
|  | Other comprehensive income |  |  |  | — |  |  |  | (218 | )
Total commodity derivatives |  |  |  |  | $$ | — |  |  | $ | (73 | )

We did not incur any hedge ineffectiveness during the three-month periods ended March 31, 2019 and 2018.

Note 7 – Fair Value Measurement

The Company bases fair value on a price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have adopted a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Inputs, other than quoted market prices included in Level 1, that are observable either directly or indirectly for the asset or liability.

Level 3: Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value.

Except for derivative instruments (see Note 6), pension liabilities, pension plan assets, a corporate owned life insurance policy and assets held for sale (see Note 12), the Company had no material financial assets and liabilities that are carried at fair value at March 31, 2019 and December 31, 2018. The carrying amounts of financial instruments comprising cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to the relatively short maturity of such instruments. The Company uses an income valuation technique to measure the fair values of its debt instruments by converting amounts of future cash flows to a single present value amount using rates based on current market expectations (Level 2 inputs).

17

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 7 – Fair Value Measurement – Continued

As of March 31, 2019, and December 31, 2018, the carrying values of the Company’s Credit Agreement indebtedness were not materially different than their estimated fair values because the interest rates on variable rate debt approximated rates currently available to the Company (see Note 6). Discount rates used to measure the fair value of the DEG Vietnam Loan and DEG China Loan are based on quoted swap rates. As of March 31, 2019, the carrying values of the DEG Vietnam Loan and DEG China Loan were $11,250 and $449, respectively, as compared to an estimated fair value of $11,325 and $450, respectively. As of December 31, 2018, the carrying value of the DEG Vietnam Loan and DEG China Loan were $11,250 and $913, respectively, as compared to an estimated fair value of $11,100 and $900, respectively.

Certain Company assets are required to be recorded at fair value on a non-recurring basis when events and circumstances indicate that the carrying value may not be recoverable. Management’s estimates used to record impairment expense are inherently uncertain and may change in future periods.

Note 8 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss)

Reclassification adjustments and other activities impacting accumulated other comprehensive income (loss) during the three-month period ended March 31, 2019 and 2018 are as follows:

|  | Defined Benefit Pension Plans |  |  | Foreign Currency Translation Adjustments |  |  | Foreign Currency Hedge Derivatives |  |  | Total |
Balance at December 31, 2018 |  | $ | (2,339 | ) |  | $ | (37,157 | ) |  | $ | (4 | ) |  | $ | (39,500 | )
Other comprehensive income (loss) before reclassifications |  |  | — |  |  |  | (4,074 | ) |  |  | 717 |  |  |  | (3,357 | )
Income tax effect of other comprehensive income (loss) before reclassifications |  |  | — |  |  |  | (177 | ) |  |  | (156 | ) |  |  | (333 | )
Amounts reclassified from accumulated other comprehensive (income) loss into net income |  |  | — |  |  |  | — |  |  |  | 49 |  | a |  | 49 |
Income taxes reclassified into net income |  |  | — |  |  |  | — |  |  |  | (11 | ) |  |  | (11 | )
Net current period other comprehensive income (loss) |  |  | — |  |  |  | (4,251 | ) |  |  | 599 |  |  |  | (3,652 | )
Balance at March 31, 2019 |  | $ | (2,339 | ) |  | $ | (41,408 | ) |  | $ | 595 |  |  | $ | (43,152 | )

(a)The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.

18

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 8 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss) – Continued

|  | Defined Benefit Pension Plans |  |  | Foreign Currency Translation Adjustments |  |  | Commodity Hedge Derivatives |  |  | Foreign Currency Hedge Derivatives |  |  | Total |
Balance at December 31, 2017 |  | $ | (2,366 | ) |  | $ | (17,555 | ) |  | $ | 277 |  |  | $ | (800 | ) |  | $ | (20,444 | )
Cumulative effect of accounting change due to adoption of ASU 2018-02 |  |  | (49 | ) |  |  | — |  |  |  | 9 |  |  |  | — |  |  |  | (40 | )
Other comprehensive income (loss) before reclassifications |  |  | — |  |  |  | 11,750 |  |  |  | — |  |  |  | 1,854 |  |  |  | 13,604 |
Income tax effect of other comprehensive income (loss) before reclassifications |  |  | — |  |  |  | (76 | ) |  |  | — |  |  |  | (498 | ) |  |  | (574 | )
Amounts reclassified from accumulated other comprehensive (income) loss into net income |  |  | — |  |  |  | — |  |  |  | (218 | ) | a |  | 258 |  | a |  | 40 |
Income taxes reclassified into net income |  |  | — |  |  |  | — |  |  |  | (68 | ) |  |  | (69 | ) |  |  | (137 | )
Net current period other comprehensive income (loss) |  |  | (49 | ) |  |  | 11,674 |  |  |  | (277 | ) |  |  | 1,545 |  |  |  | 12,893 |
Balance at March 31, 2018 |  | $ | (2,415 | ) |  | $ | (5,881 | ) |  | $ | — |  |  | $ | 745 |  |  | $ | (7,551 | )

(a) | The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.

We expect all of the existing gains and losses related to foreign currency derivatives reported in accumulated other comprehensive income (loss) as of March 31, 2019 to be reclassified into earnings during the next twelve months. See Note 6 for additional information about derivative financial instruments and the effects from reclassification to net income.

Note 9 – Revenue Recognition

The aggregate amount of transaction price allocated to material rights that remain unsatisfied as of March 31, 2019 is $1,383. We expect to recognize into revenue, 58% of this balance in the next 9 months, and the remaining 21%, 12%, 5% and 4% in 2020, 2021, 2022 and 2023, respectively.

Unearned revenue by segment was as follows:

| March 31, 2019 |  |  | December 31, 2018 |
Automotive | $ | 1,383 |  |  | $ | 1,597 |
Industrial |  | — |  |  |  | — |
Total | $ | 1,383 |  |  | $ | 1,597 |

19

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 9 – Revenue Recognition – Continued

Changes in unearned revenue were as follows:

Three Months Ended March 31, 2019 |  |  |
Balance, beginning of period | $ | 1,597 |
Additions to unearned revenue |  | 227 |
Reclassified to revenue |  | (281 | )
Reclassified to held for sale |  | (161 | )
Currency impacts |  | 1 |
Balance, end of period | $ | 1,383 |

Revenue allocated to remaining performance obligations represents contracted revenue that has not yet been recognized, which includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods.

Total costs to obtain a contract that were recognized on the consolidated condensed balance sheets as of March 31, 2019 and December 31, 2018 were immaterial.

Note 10 – New Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Leases

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standard Update (ASU) 2016-02, “Leases (Topic 842).” Topic 842 was subsequently amended by ASU 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU 2018-10, Codification Improvements to Topic 842, Leases; and ASU 2018-11, Targeted Improvements. The update and related amendments require lessees to recognize on their balance sheet a liability to make payments and a right-of-use asset representing its right to use the underlying asset for the lease term. Leases are to be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of income.

The update’s requirement to recognize the rights and obligations resulting from leases as assets and liabilities by lessees increases transparency and comparability of lease transactions between organizations. New lessee disclosure requirements to provide information about the use of significant assumptions and judgements to identify and measure right-of-use assets and lease liabilities enhance the representation of leasing transactions in financial statement note disclosures.

We elected to adopt ASU 2016-02 and related amendments on its effective date, January 1, 2019, and recognized a cumulative-effect adjustment to the opening balance in retained earnings. Financial information has not been updated and disclosure under the new standard have not been provided to dates and periods before January 1, 2019. We elected the package of practical expedients provided in ASU 2016-02, which permits companies not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. We elected the use-of-hindsight to determine whether lease terms include periods covered by the lessee’s option to extend or terminate a lease, whether to purchase the underlying asset at the end of the lease agreement, and in assessing impairment of operating lease right-of-use assets. Finally, we elected not to assess whether existing or expired land easements that were not previously accounted for as leases are or contain a lease. Land easements previously accounted for as leases are not eligible for this practical expedient.

ASU 2016-02 did not have an impact on our consolidated condensed statement of income for the three-month period ended March 31, 2019, but had a significant impact on our consolidated condensed balance sheet as of March 31, 2019. Gentherm recognized $17,146 and $16,697 in new operating lease right-of-use assets and lease liabilities, respectively, on our consolidated condensed balance sheet for the right to use lease assets, a difference of $449. Gentherm recognized $261 of this difference as an adjustment to the 2019 opening balance in retained earnings, net of tax effects totaling $114. The remaining $74 difference between operating lease right-of-use assets and lease liabilities for leases that existed as of the adoption date was recognized as a reduction to prepaid and other current assets.

20

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 10 – New Accounting Pronouncements – Continued

ASU 2016-02 provides lessees with practical expedients applicable on an ongoing basis, beyond the period of adoption. First, lessees may elect, by class of underlying asset, to not recognize operating lease right-of-use assets and lease liabilities from leases with an original lease term of 12 months or less. For entities that elect this accounting policy for short term leases, lease payments from short term leases are recognized on a straight-line basis over the lease term in the Company’s consolidated condensed statement of income. Second, lessees may elect, by class of underlying assets, to not separate nonlease components that are associated with lease components in a lease agreement and instead to account for them together as a single lease component. The Company elected these ongoing practical expedients during the three-month period March 31, 2019 and applied them to all classes of leased assets.

Derivatives and Hedging

In October 2018, the FASB issued ASU 2018-16, “Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes.” ASU 2018-16 adds the OIS Rate based on SOFR to the list of eligible benchmark interest rates that can be used for hedge accounting purposes under Topic 815. SOFR is a volume-weighted median interest rate that is calculated daily based on overnight transactions from the prior day’s trading activity in specified segments of the U.S. Treasury repo market. The designation of the OIS rate based on SOFR as a benchmark interest rate for hedge accounting purposes is in response to ongoing concerns about the sustainability of LIBOR and the Federal Reserve’s intent to have a suitable alternative to USD LIBOR that is more firmly based on actual transactions in a robust market. Prior to this update, the only eligible benchmark interest rates were the interest rates on direct Treasury obligations of the U.S. government (UST), the LIBOR swap rate, the OIS Rate based on the Fed Funds Effective Rate and the Securities Industry and Financial Markets Association (SIFMA) Municipal Swap Rate.

ASU 2018-16 is effective for annual and interim periods beginning after December 15, 2018. Early adoption of the amendments in this update is permitted. The amendments in this update should be adopted on a prospective basis for qualifying new or redesigned hedging relationships entered into on or after the date of adoption. We have adopted ASU 2018-16 and related amendments effective January 1, 2019. Since we did not execute any U.S. benchmark interest rate transactions during the adoption of this update and related amendments, the update and related amendments did not have an impact on the Company’s financial statements for three-month period ended March 31, 2019.

Recently Issued Accounting Pronouncements Not Yet Adopted

Cloud Computing Arrangements That Are Service Contracts

In August 2018, the FASB issued ASU 2018-15, “Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” ASU 2018-15 provides guidance on when costs incurred to implement a hosting arrangement that is a service contract are and are not capitalized, aligning with the guidance for capitalizing implementation costs incurred to develop or obtain internal-use software. Entities must first determine the project stage of the implementation activity; depending on their nature, costs for implementation activities in the application development stage are capitalized and costs incurred during the preliminary project and post-implementation stages are expensed as the activities are performed. Capitalized implementation costs should be amortized over the term of the hosting arrangement on a straight-line basis and presented in the same line items in the statement of income as the expense for fees for the associated hosting arrangements. Similarly, capitalized implementation costs should be presented in same line item in the balance sheet as prepaid fees for the associated hosting arrangement and cash flows from capitalized implementation costs should be classified in the same manner as cash flows for the fees for the associated hosting arrangement.

ASU 2018-15 is effective for annual and interim periods beginning after December 15, 2019. Early adoption of the amendments in this update is permitted, including adoption in any interim period for which financial statements have not yet been issued. ASU 2018-15 permits two methods of adoption: prospectively to costs for activities performed on or after the date the entity first applies the content from the update, or retrospectively to all periods presented. We are currently in the process of determining the impact implementation of ASU 2018-15 will have on the Company’s financial statements and note disclosures.

21

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 10 – New Accounting Pronouncements – Continued

Retirement Benefits

In August 2018, the FASB issued ASU 2018-14, “Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20): Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans.” The amendments in ASU 2018-14 were developed using the concepts incorporated in the FASB’s Concepts Statement, Conceptual Framework for Financial Reporting – Chapter 8: Notes to Financial Statements, which were finalized in August 2018. The amendments in this update remove the following disclosure requirements, among others, from Subtopic 715-20:

| 1) | The amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year.

| 2) | The amount and timing of plan assets expected to be returned to the employer.

The following disclosure requirements were added to Subtopic 715-20:

| 1) | The weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates.

| 2) | An explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period.

ASU 2018-14 is effective for annual periods ending after December 15, 2020. Early adoption of the amendments in this update are permitted. Entities should apply the amendments in this update on a retrospective basis to all periods presented. We are currently in the process of determining the impact implementation of ASU 2018-14 will have on the Company’s financial statement note disclosures.

Fair Value Measurement

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.” The amendments in ASU 2018-13 were developed using the concepts incorporated in the FASBs Concepts Statement, Conceptual Framework for Financial Reporting – Chapter 8: Notes to Financial Statements, which were finalized in August 2018. The amendments in this update remove the following disclosure requirements from Topic 820:

| 1) | The amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy.

| 2) | The policy for timing of transfer between levels.

| 3) | The valuation processes for Level 3 fair value measurements.

The following disclosure requirements were added to Topic 820:

| 1) | The changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period.

| 2) | The range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements.

ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019. Early adoption of disclosures that are removed is permitted, but adoption is delayed for the new additional disclosures until their effective date. The amendments in ASU 2018-13 that provide for new additional disclosure should be applied on a prospective basis, while all other amendments should be applied retrospectively to all periods presented upon their effective date. We are currently in the process of determining the impact implementation of ASU 2018-13 will have on the Company’s financial statement note disclosures.

22

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 11 – Leases

The Company has operating leases for office, manufacturing and research and development facilities, as well as leases for the ground with which certain manufacturing facilities sit atop. We also have operating leases for office equipment and automobiles. Excluding ground leases, our leases have remaining lease terms ranging from 1 year to 8 years and may include options to extend the lease for an additional term equal to the original term of the lease. Ground operating leases have remaining lease terms that range from 30 to 45 years and some which specify that the end of the lease term is at the discretion of the lessee. We do not have lease arrangements with related parties.

Information about Gentherm’s total lease costs for the three months ended March 31, 2019 is as follows:

Three Months Ended March 31, 2019 |  |  |
Lease cost |  |  |
Operating lease cost | $ | 1,333 |
Short-term lease cost |  | 955 |
Sublease income |  | (13 | )
Total lease cost | $ | 2,275 |
Supplemental Cash Flow Information |  |  |
Gain on sale and leaseback transactions, net | $ | 207 |
Cash paid for amounts included in the measurement of lease liabilities: |  |  |
Operating cash flows from operating leases | $ | 1,392 |
Right-of-use lease assets obtained in exchange for lease obligations: |  |  |
Operating leases | $ | 2,234 |
Weighted Average Remaining Lease Term |  |  |
Operating leases |  | 5.7 years |
Weighted Average Discount Rate |  |  |
Operating leases |  | 5.4 | %

A summary of operating leases as of March 31, 2019, under all non-cancellable operating leases with terms exceeding one year is as follows:

2019 (excluding the three-month period ended March 31, 2019) |  | $ | 4,100 |
2020 |  |  | 4,434 |
2021 |  |  | 2,598 |
2022 |  |  | 1,626 |
2023 |  |  | 934 |
2024 or later |  |  | 2,726 |
Total future minimum lease payments |  |  | 16,418 |
Less imputed interest |  |  | (2,908 | )
Total |  |  | 13,510 |

23

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 12 – Assets and Liabilities Held for Sale

During 2018, the Company determined that GPT met the held for sale criteria and recognized $2,190 in impairment loss on assets held for sale. During the three-month period ended March 31, 2019, the Company determined an equity investment met the held for sale criteria and recognized an impairment of $3,486. During the three-month period ended March 31, 2019, the Company recognized and additional $6,998 in impairment losses on assets held for sale. See Note 2 for information about the Company’s held for sale accounting policy, including a description of the criteria necessary for a disposal group to qualify for classification as held for sale. GPT did not meet the criteria to be classified as a discontinued operation.

The assets and liabilities of the disposal group classified as held for sale as of March 31, 2019 are as follows:

Accounts receivable, net | $ | 2,149 |
Inventory, net |  | 5,891 |
Prepaid expenses and other assets |  | 240 |
Operating lease right-of-use assets |  | 4,143 |
Investment |  | 1,000 |
Property and equipment, net |  | 7,291 |
Other intangible assets, net |  | 993 |
Deferred income tax assets |  | 4,490 |
Impairment loss |  | (9,188 | )
Total assets held for sale | $ | 17,009 |
Accounts payable | $ | 536 |
Accrued liabilities |  | 2,326 |
Operating lease liabilities |  | 4,147 |
Total liabilities held for sale | $ | 7,009 |

Management’s estimates used to record impairment expense are inherently uncertain and may change in future periods.

24

ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

This Report contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our goals, beliefs, plans and expectations about our prospects for the future and other future events, such as our ability to execute our new strategic plan, our ability to finance sufficient working capital, the amount of availability under our credit agreement and other indebtedness, our ability to continue to maintain or increase sales and profits of our operations, and the sufficiency of our cash balances and cash generated from operating, investing and financing activities for our future liquidity and capital resource needs. Reference is made in particular to forward-looking statements included in this “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 1 to the consolidated condensed financial statements. Such statements may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “anticipate”, “intend”, “continue”, or similar terms, variations of such terms or the negative of such terms. The forward-looking statements included in this Report are made as of the date hereof or as of the date specified and are based on management’s current expectations and beliefs. Such statements are subject to a number of assumptions, risks, uncertainties and other factors, which are set forth in “Item 1A. Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2018, and subsequent reports filed with or furnished to the Securities and Exchange Commission, and which could cause actual results to differ materially from that described in the forward-looking statements. Except as required by law, we expressly disclaim any obligation or undertaking to update any forward-looking statements to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our consolidated financial statements and related notes thereto included elsewhere in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2018.

Overview

Gentherm Incorporated is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies. Our products provide solutions for automotive passenger climate comfort and convenience, battery thermal management and cell connecting systems, as well as patient temperature management within the health care industry. Our automotive products can be found on the vehicles of nearly all major automotive manufacturers operating in North America, Europe and Asia. We operate in locations aligned with our major customers’ product strategies to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies and new applications from existing technologies to create product and market opportunities for a wide array of thermal management solutions.

Our automotive products are sold to automobile and light truck OEMs or their tier one suppliers. Inherent to the automotive supplier market are costs and commitments that are incurred well in advance of the receipt of orders and resulting revenues from customers. This is due in part to automotive manufacturers requiring the design, coordination and testing of proposed new components and sub-systems. Revenues from these expenditures are typically not realized for two to three years due to this development cycle.

Reportable Segments

The Company has two reportable segments for financial reporting purposes: Automotive and Industrial. See Note 4 to the consolidated condensed financial statements for a description of our reportable segments as well as their proportional contribution to the Company’s reported product revenues and operating income. The financial information used by our chief operating decision maker to assess operating performance and allocate resources is based on these reportable segments.

Sale of Cincinnati Sub-Zero Industrial Chamber Business (CSZ-IC)

On February 1, 2019, as part of the Company’s Fit-for-Growth initiative to eliminate investments in non-core businesses, we completed the sale of the Cincinnati Sub-Zero industrial chamber business (“CSZ-IC”) and former Cincinnati Sub-Zero headquarters facility to Weiss Technik North America, Inc. for total cash proceeds of $47.5 million, including $2.5 million of the cash proceeds were placed into an escrow account for a period of up to one year as partial security for the Company’s obligations under the sale agreement. In connection with the sale, Gentherm entered into an operating lease agreement for a portion of the office and manufacturing building space purchased by Weiss Technik North America, Inc. The Company recognized a $5.0 million pre-tax gain on the sale of CSZ-IC during the three-month period ended March 31, 2019.

25

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our consolidated condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. For discussion of our significant accounting policies, see Note 2, “Summary of Significant Accounting Policies and Basis of Presentation,” to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018. With the exception of leases, there have been no significant accounting policy changes during the three-month period ended March 31, 2019. See Note 10 for information about the adoption of ASU 2016-02, “Leases”.

Results of Operations First Quarter 2019 Compared with First Quarter 2018

Product revenues. Product revenues by product category, in thousands, for the three-month period ended March 31, 2019 (“First Quarter 2019) and 2018 (“First Quarter 2018) are as follows:

|  | Three Months Ended March 31, |
|  | 2019 |  |  | 2018 |  |  | % Change
Climate Control Seats (CCS) |  | $ | 94,354 |  |  | $ | 88,218 |  |  | 7.0 |  | %
Seat Heaters |  |  | 73,920 |  |  |  | 84,220 |  |  | (12.2 | ) | %
Steering Wheel Heaters |  |  | 16,970 |  |  |  | 17,557 |  |  | (3.3 | ) | %
Automotive Cables |  |  | 23,749 |  |  |  | 26,865 |  |  | (11.6 | ) | %
Battery Thermal Management (BTM)(a) |  |  | 10,745 |  |  |  | 4,161 |  |  | 158.2 |  | %
Electronics |  |  | 12,852 |  |  |  | 15,188 |  |  | (15.4 | ) | %
Other Automotive |  |  | 9,767 |  |  |  | 6,212 |  |  | 57.2 |  | %
Subtotal Automotive |  | $ | 242,357 |  |  | $ | 242,421 |  |  | — |  | %
Remote Power Generation (GPT) |  |  | 3,959 |  |  |  | 4,662 |  |  | (15.1 | ) | %
Industrial Chambers |  |  | 3,418 |  |  |  | 10,213 |  |  | (66.5 | ) | %
Gentherm Medical |  |  | 8,187 |  |  |  | 7,290 |  |  | 12.3 |  | %
Subtotal Industrial |  | $ | 15,564 |  |  | $ | 22,165 |  |  | (29.8 | ) | %
Total Company |  | $ | 257,921 |  |  | $ | 264,586 |  |  | (2.5 | ) | %

| a) | Battery Thermal Management or BTM product revenues include Gentherm’s automotive grade, low cost, heat resistant fans and blowers used by customer for battery cooling through ventilation and production level shipments of the advanced TED based active cool system.

Product revenues during First Quarter 2019 were $257.9 million compared with product revenues of $264.6 million during First Quarter 2018, a decrease of $6.7 million, or 2.5%. Product revenues in the automotive segment decreased $64 thousand to $242.4 million during First Quarter 2019 as compared to First Quarter 2018. During First Quarter 2019, the relative market value of the Euro declined against the US Dollar, which had a negative impact on our product revenues from sales to customers in Europe, much of which are denominated in European Euros. Adjusting for the impact from foreign currency translation, First Quarter 2019 automotive product revenues would have been $249.1 million, or 2.8% higher than automotive revenues during First Quarter 2018. The growth in product revenues in the automotive segment was driven by higher sales of CCS and BTM, partially offset by lower sales of seat heaters, steering wheel heaters and automotive cables.

Our automotive segment revenues outperformed automotive vehicle product volumes during First Quarter 2019, despite a 6.7% decrease in actual light vehicle production in the Company’s key markets, including North America, Europe, Japan, Korea and China, as compared to light vehicle production during First Quarter 2018.

Product revenues in the industrial segment revenues decreased $6.6 million, or 29.8%, to $15.6 million during First Quarter 2019 due to the sale of CSZ-IC on February 1, 2019. Product revenues from GPT during First Quarter 2019 were $4.0 million compared to $4.7 million during First Quarter 2018, a decrease of $703 thousand, or 15.1%. These decreases were partially offset by higher production revenues at Gentherm Medical. Gentherm Medical product revenues increased $900 thousand, or 12.3%, to $8.2 million during First Quarter 2019. At March 31, 2019, GPT was classified as held for sale on Gentherm’s consolidated condensed balance sheet.

Cost of Sales. Cost of sales was $182.6 million during First Quarter 2019 compared to $183.3 million during First Quarter 2018, a decrease of $730 thousand, or 0.4%. Adjusting for the impact from foreign currency translation, cost of sales during First Quarter

26

2019 would have been $187.3 million, or 2.2% higher as compared to First Quarter 2018. T h is increase was due to the higher automotive product revenues, increased tariffs, higher labor costs and higher product costs on BTM associated with the launch phase of the new actively cooled technology programs. These items were partially offset by savings realized from Fit-for-Growth cost reduction initiatives.

Net Research and Development Expenses. Net research and development expenses were $18.9 million during First Quarter 2019 compared to $23.3 million during First Quarter 2018, a decrease of $4.4 million, or 18.9%. The decrease in net research and development expenses is a direct result of the Company’s focused portfolio and Fit-for-Growth cost reduction initiatives.

Research and development reimbursement totaled $3.7 million during First Quarter 2019 compared to $2.4 million during First Quarter 2018. This increase was mainly attributable to higher-than-normal development expense reimbursements paid by customers for products launched during the period.

Selling, General and Administrative Expenses. Selling, general and administrative expenses were $32.6 million during First Quarter 2019, a decrease of $3.8 million, or 10.5%, from $36.4 million during First Quarter 2018. The decrease was primarily driven by the impact of the Fit-for-Growth cost reduction initiatives and the sale of CSZ-IC on February 1, 2019.

Restructuring expenses. The Company recognized $1.9 million in restructuring expenses during First Quarter 2019 associated with the Fit-for-Growth program compared to $865 thousand recognized in First Quarter 2018, an increase of $1.1 million or 121.3%. These costs primarily related to the sale of CSZ-IC and the marketing of GPT to potential buyers.

Foreign currency gain (loss). During First Quarter 2019 we incurred a net foreign currency gain of $203 thousand which included a net realized loss of $791 thousand and a net unrealized gain of $994 thousand. The unrealized loss was primarily the result of holding significant amounts of U.S. Dollar cash at our subsidiaries in Europe which have the European Euro as the functional currency and due to certain intercompany relationships between these European subsidiaries and our U.S. based companies. During First Quarter 2018, we had a foreign currency loss of $4.6 million which included an unrealized loss of $3.6 million. In comparison to First Quarter 2018, the foreign currency impact during First Quarter 2019 was lower due to a smaller change in currency exchange rates during First Quarter 2019 as compared to First Quarter 2018.

Gain on sale of business. On February 1, 2019, as part of Company’s Fit-for-Growth initiative to eliminate investments in non-core businesses, we completed the sale of the CSZ-IC and former Cincinnati Sub-Zero headquarters facility to Weiss Technik North America, Inc. for total cash proceeds of $47.5 million, including $2.5 million of cash proceeds placed into an escrow account for a period of up to one year. The Company recognized a pre-tax gain of $5.0 million on the sale of CSZ-IC during the three-month period ended March 31, 2019.

Impairment loss. During the First Quarter 2019, the Company recorded an impairment loss totaling $10.5 million associated with the Company’s plans to divest GPT. The loss is not expected to be deductible for income tax purposes.

Income Tax Expense. We recorded an income tax expense of $6.9 million during First Quarter 2019 on earnings before income tax of $15.3 million. The pre-tax earnings amount included the non-deductible impairment loss of $10.5 million. Adjusting for the impairment loss, the effective tax rate was 26.7% for the First Quarter 2019. During First Quarter 2018, we recorded an income tax expense of $3.0 million on earnings before tax of $16.0 million, or 19.0%. The effective tax rate for First Quarter 2018 differed from the Federal statutory rate of 21% primarily due to certain intercompany transactions which disproportionately benefited lower tax rate jurisdictions, partly offset by unfavorable effects from the U.S. tax reform, such as global intangible low-tax income (“GILTI”), enacted in December 2017. The effective tax rate for First Quarter 2019 was higher than the Federal statutory rate of 21% primarily due to the impact of higher statutory rates for our subsidiaries operating in foreign jurisdictions and effects from the U.S. tax reform, such as GILTI.

Liquidity and Capital Resources

Cash and Cash Flows

The Company has funded its financial needs primarily through cash flows from operating activities and equity and debt financings. Our new strategic plan sets forth a capital allocation strategy that includes a targeted debt-to-earnings leverage ratio and allows for some of our cash flows to be paid back to investors through Common Stock repurchases. On June 25, 2018, our Board of Directors increased the Company’s stock repurchase authorization to $300 million, of which $138.6 million of availability remained as of March 31, 2019. This authorization expires on December 16, 2020. Based on its current operating plan, management believes cash and cash equivalents at March 31, 2019, together with cash flows from operating activities, and borrowings available under our credit agreement, are sufficient to meet operating and capital expenditure needs, and to service debt, for at least the next 12 months.

27

However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and adversely affect our results of operations and financial condition. In addition, it is likely that we will need to comp lete one or more equity or debt financings if we consummate any significant acquisition or several smaller acquisitions. There can be no assurance that such capital will be available at all or on reasonable terms, which could adversely affect our future o perations and business strategy.

The following table represents our cash and cash equivalents and restricted cash:

|  | Three Months Ended March 31, 2019 |  |  | Three Months Ended March 31, 2018 |
|  | (In thousands) |
Cash, cash equivalents and restricted cash at beginning of period |  | $ | 39,620 |  |  | $ | 103,172 |
Cash provided by operating activities |  |  | 6,881 |  |  |  | 5,590 |
Cash provided by (used in) investing activities |  |  | 42,378 |  |  |  | (8,393 | )
Cash used in financing activities |  |  | (47,401 | ) |  |  | (35,400 | )
Foreign currency effect on cash and cash equivalents |  |  | (209 | ) |  |  | 5,513 |
Cash, cash equivalents and restricted cash at end of period |  | $ | 41,269 |  |  | $ | 70,482 |

Cash Flows From Operating Activities

We manage our cash, cash equivalents and restricted cash in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. The following table compares the cash flows from operating activities during First Quarter 2019 and First Quarter 2018:

|  | Three Months Ended March 31, |
|  | 2019 |  |  | 2018 |  |  | Change |
Operating Activities: |  | (In thousands) |
Net income |  | $ | 8,414 |  |  | $ | 12,966 |  |  | $ | (4,552 | )
Non-cash adjustments to reconcile net income to cash provided by operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 11,052 |  |  |  | 12,892 |  |  |  | (1,840 | )
Deferred income taxes |  |  | 1,749 |  |  |  | (707 | ) |  |  | 2,456 |
Stock compensation |  |  | 1,968 |  |  |  | 2,202 |  |  |  | (234 | )
Defined benefit plan (income) expense |  |  | (617 | ) |  |  | 298 |  |  |  | (915 | )
Provision for doubtful accounts |  |  | 229 |  |  |  | 41 |  |  |  | 188 |
Loss on sale of property and equipment |  |  | 178 |  |  |  | 85 |  |  |  | 93 |
Operating lease expense |  |  | 1,333 |  |  |  | — |  |  |  | 1,333 |
Impairment loss |  |  | 10,484 |  |  |  | — |  |  |  | 10,484 |
Gain on sale of business |  |  | (4,970 | ) |  |  | — |  |  |  | (4,970 | )
Net income before changes in operating assets and liabilities |  |  | 29,820 |  |  |  | 27,777 |  |  |  | 2,043 |
Changes in operating assets and liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Accounts receivable |  |  | (8,293 | ) |  |  | (9,691 | ) |  |  | 1,398 |
Inventory |  |  | (229 | ) |  |  | 1,903 |  |  |  | (2,132 | )
Prepaid expenses and other assets |  |  | (5,553 | ) |  |  | (4,881 | ) |  |  | (672 | )
Accounts payable |  |  | (2,079 | ) |  |  | 1,290 |  |  |  | (3,369 | )
Accrued liabilities |  |  | (6,785 | ) |  |  | (10,808 | ) |  |  | 4,023 |
Net cash provided by operating activities |  | $ | 6,881 |  |  | $ | 5,590 |  |  | $ | 1,291 |

28

Cash provided by operating activities during First Quarter 201 9 was $6.9 million, representing an increase of $1.3 million from cash provided in operating activiti es during First Quarter 201 8, which was $5.6 million. The following table highlights significant differences between the operating cash flows for the three-month periods ending March 3 1, 201 9 and 201 8, respectively:

(In thousands)
Net cash provided by operating activities during First Quarter 2018 | $ | 5,590 |
Increase from higher net income before changes in operating assets and liabilities |  | 2,043 |
Changes in working capital, net |  | 6,337 |
Other changes in working capital, net. |  | (7,089 | )
Net cash provided by operating activities during First Quarter 2019 | $ | 6,881 |

Net cash provided by operating activities before changes in operating assets and liabilities increased during First Quarter 2019 due to non-cash impairment losses of $10.5 million, partially offset by a $5.0 gain recognized on the sale of CSZ-IC. Additionally, working capital, net provided favorable cash flows related to accounts payable and accrued liabilities and unfavorable amounts related to accounts receivable, inventory, and prepaid expenses and other assets.

The following table illustrates changes in working capital during First Quarter 2019:

(In thousands)
Working capital at December 31, 2018 | $ | 267,679 |
Increase in cash, cash equivalents and restricted cash |  | 1,878 |
Impairment loss on assets classified as held for sale |  | (10,484 | )
Foreign currency effect on working capital |  | (1,018 | )
Increase in accounts receivable |  | 8,627 |
Decrease in tax receivables |  | (2,415 | )
Increase in inventory |  | 84 |
Increase in prepaid expenses and other assets |  | 4,223 |
Decrease in accounts payable |  | 1,694 |
Decrease in accrued liabilities |  | 1,815 |
Decrease in working capital due to the sale of a business |  | (42,530 | )
Increase in net current assets classified as held for sale |  | 5,974 |
Working capital at March 31, 2019 | $ | 235,527 |

The following table highlights significant transactions that contributed to the increase in cash, cash equivalents and restricted cash during the three-month period ended March 31, 2019:

(in Thousands)
Net cash provided by operating activities | $ | 6,881 |
Purchases of property and equipment |  | (5,150 | )
Repayments of Debt |  | (49,627 | )
Borrowings from U.S. Revolving Note |  | 10,428 |
Stock repurchases |  | (8,040 | )
Proceeds from the sale of CSZ-IC |  | 47,500 |
Other items |  | (114 | )
Increase in cash | $ | 1,878 |

In addition to these transactions, working capital was impacted by increases in accounts receivable, inventory, and prepaid expenses and other assets, and decreases in accounts payable, accrued liabilities and tax receivables. The changes in current assets and liabilities reflect the classification of additional assets related to GPT (disposal group) as held for sale during First Quarter 2019. All assets and liabilities of the disposal group are classified as held for sale within current assets and current liabilities, respectively, on the Company’s consolidated balance sheet as of March 31, 2019. See Note 12 to our consolidated condensed financial statement for additional information about the assets and liabilities classified as held for sale.

29

Cash Flows From Investing Activities

Cash used in investing activities was $42.4 million during First Quarter 2019, reflecting cash proceeds of $47.5 million related to the sale of CSZ-IC, partially offset by purchases of property and equipment related to the expansion of production capacity, totaling $5.1 million.

Cash Flows From Financing Activities

Cash used in financing activities was $47.4 million during First Quarter 2019, reflecting payments of principal on the U.S. Revolving Note, the DEG China Loan and the DEG Vietnam Loan totaling $49.6 million in aggregate partially offset by additional borrowings on the U.S. Revolving Note totaling $10.4 million. As of March 31, 2019, the total availability under the U.S. Revolving Note was $261.1 million. Cash was also paid in First Quarter 2019 for cancellations of restricted stock awards totaling $376 thousand, and for the repurchase of Common Stock totaling $8.0 million.

Off-Balance Sheet Arrangements

We use letters of credit to guarantee our performance under specific construction contracts executed by our subsidiaries, GPT and Gentherm Medical. The expiration dates of the letter of credit contracts coincide with the expected completion date of the contract. Extensions are normally made if performance obligations continue beyond the expected completion date. At March 31, 2019, we had outstanding letters of credit of $11 thousand, a decrease from $455 thousand at December 31, 2018.

30

ITEM 3. | QUANTITATIVE AND QUALI TATI VE DISCLOSURES ABOUT MARKET RISK

Our exposure to market risk for changes in interest rates relates primarily to our debt obligations and foreign currency contracts. We have in the past, and may in the future, place our investments in bank certificates of deposits, debt instruments of the U.S. government, and in high-quality corporate issuers.

We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $24.1 million and $33.3 million outstanding at March 31, 2019 and December 31, 2018, respectively.

The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years. No commodity swap contracts were outstanding at March 31, 2019 or at December 31, 2018.

We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive income (loss) in the consolidated condensed balance sheet. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive income (loss) is recorded in earnings in the consolidated condensed statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated condensed statements of income. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term. Information related to the fair values of all derivative instruments in our consolidated condensed balance sheet as of March 31, 2019 is set forth in Note 6 to the consolidated condensed financial statements included herein.

Interest Rate Sensitivity

The table presents principal cash flows and related weighted average interest rates by expected maturity dates for each of the Company’s debt obligations. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in U.S. dollars ($USD) or European Euros (€EUR), as indicated in parentheses.

March 31, 2019

|  | Expected Maturity Date |
|  | 2019 |  |  | 2020 |  |  | 2021 |  |  | 2022 |  |  | 2023 |  |  | Thereafter |  |  | Total |  |  | Fair Value |
|  | (In thousands except rate information) |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Long Term Debt: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fixed Rate (€EUR) |  | $ | 449 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  | $ | 449 |  |  | $ | 450 |
Fixed Interest Rate |  |  | 4.25 | % |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4.25 | % |  |  |  |
Variable Rate ($USD) |  |  | — |  |  |  | — |  |  |  | 88,854 |  |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | 88,854 |  |  | $ | 88,854 |
Average Interest Rate |  |  |  |  |  |  |  |  |  |  | 4.00 | % |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4.00 | % |  |  |  |
Fixed Rate ($USD) |  | $ | 2,500 |  |  | $ | 2,500 |  |  | $ | 2,500 |  |  | $ | 2,500 |  |  | $ | 1,250 |  |  |  | — |  |  | $ | 11,250 |  |  | $ | 11,325 |
Fixed Interest Rate |  |  | 5.21 | % |  |  | 5.21 | % |  |  | 5.21 | % |  |  | 5.21 | % |  |  | 5.21 | % |  |  |  |  |  |  | 5.21 | % |  |  |  |

31

Exchange Rate Sensitivity

The table below provides information about the Company’s foreign currency forward exchange rate agreements that are sensitive to changes in foreign currency exchange rates. The table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates for each type of foreign currency forward exchange agreement. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

March 31, 2019

|  | Expected Maturity or Transaction Date |
Anticipated Transactions And Related Derivatives |  | 2019 |  |  | 2020 |  |  | 2021 |  |  | 2022 |  |  | 2023 |  |  | Thereafter |  |  | Total |  |  | Fair Value |
|  | (In thousands except rate information) |
$U.S. functional currency |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Forward Exchange Agreements: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(Receive MXN/Pay USD$) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total Contract Amount |  | $ | 24,114 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  | $ | 24,114 |  |  | $ | 857 |
Average Contract Rate |  |  | 20.53 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20.53 |  |  |  |  |

ITEM 4. | CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2019, our disclosure controls and procedures were not effective due to a material weakness in internal control over financial reporting that was disclosed in our Annual Report on Form 10-K for the year ended December 31, 2018.

As previously described in Part II, Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2018, we began implementing a remediation plan to address the material weakness mentioned above. The material weakness will not be considered remediated, until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. We expect that the remediation of this material weakness will be completed prior to the end of 2019.

(b) Changes in Internal Control over Financial Reporting

During the three-month period ended March 31, 2019, we implemented new lease accounting processes in conjunction with the adoption of ASU 2016-02, "Leases," on January 1, 2019. These implementations resulted in a material change in a component of our internal control over financial reporting.

Except with respect to the remediation efforts referenced above and the changes related to the adoption of ASU 2016-02, there were no changes in the Company’s internal control over financial reporting during the three-month period ended March 31, 2019, that have materially affected, or are reasonable likely to materially affect, the Company’s internal control over financial reporting.

32

PART II OTHER INFORMATION

ITEM 1. | LEGAL PROCEEDINGS

We are subject to litigation from time to time in the ordinary course of business, however there is no current material pending litigation to which we are a party and no material legal proceeding was terminated, settled or otherwise resolved during the three-month period ended March 31, 2019.

ITEM 1A. | RISK FACTORS

There were no material changes in our risk factors previously disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018. You should carefully consider the risks and uncertainties described therein.

ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities During First Quarter 2019

Period |  |  | (a) Total Number of Shares Purchased (1) |  |  | (b) Average Price Paid per Share |  |  | (c) Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs |  |  | (d) Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (2)
January 1, 2019 to January 31, 2019 |  |  |  |  | 153,967 |  |  |  | $ | 40.04 |  |  |  |  | 153,967 |  |  |  | $ | 140,435,896
February 1, 2019 to February 28, 2019 |  |  |  |  | 46,414 |  |  |  | $ | 40.42 |  |  |  |  | 46,414 |  |  |  | $ | 138,559,799
March 1, 2019 to March 31, 2019 |  |  |  |  | — |  |  |  | $ | — |  |  |  |  | — |  |  |  | $ | 138,559,799

| (1) | All shares were purchased on the open-market in accordance with Gentherm’s Stock Repurchase Program, including, in part, pursuant to a plan adopted by the Company in accordance with Rule 10b5-1 promulgated by the U.S. Securities and Exchange Commission.

| (2) | The Stock Repurchase Program authorizes Gentherm to repurchase shares up to $300 million. The Stock Repurchase Program expires on December 16, 2020. The authorization of this Stock Repurchase Program does not require that the Company repurchase any specific dollar value or number of share and may be modified, extended or terminated by the Company’s Board of Directors at any time.

33

ITEM 6. | EXHIBI TS

Exhibits to this Report are as follows:

|  |  |  |  |  | Incorporated by Reference
Exhibit Number |  | Exhibit Description |  | Filed Herewith |  | Form |  | Period Ending |  | Exhibit / Appendix Number |  | Filing Date
10.1 |  | Amended and Restated Gentherm Incorporated Senior Level Performance Bonus Plan |  |  |  | 10-K |  | 12/31/18 |  | 10.2 |  | 2/26/19
31.1 |  | Section 302 Certification – CEO |  | X |  |  |  |  |  |  |  |
31.2 |  | Section 302 Certification – CFO |  | X |  |  |  |  |  |  |  |
32.1** |  | Section 906 Certification – CEO |  | X |  |  |  |  |  |  |  |
32.2** |  | Section 906 Certification – CFO |  | X |  |  |  |  |  |  |  |
101.INS |  | XBRL Instance Document. |  | X |  |  |  |  |  |  |  |
101.SCH |  | XBRL Taxonomy Extension Schema Document. |  | X |  |  |  |  |  |  |  |
101.CAL |  | XBRL Taxonomy Extension Calculation Linkbase Document. |  | X |  |  |  |  |  |  |  |
101.DEF |  | XBRL Taxonomy Extension Definition Linkbase Document. |  | X |  |  |  |  |  |  |  |
101.LAB |  | XBRL Taxonomy Extension Label Linkbase Document. |  | X |  |  |  |  |  |  |  |
101.PRE |  | XBRL Taxonomy Extension Presentation Linkbase Document. |  | X |  |  |  |  |  |  |  |

* Indicates management contract or compensatory plan or arrangement

** Documents are furnished not filed

34

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Gentherm Incorporated
/s/ PHILLIP EYLER
Phillip Eyler
President and Chief Executive Officer
(Principal Executive Officer)
Date: May 1, 2019

/s/ MATTEO ANVERSA
Matteo Anversa
Executive Vice President, Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
Date: May 1, 2019

35